PMID- 11852966 OWN - NLM STAT- MEDLINE DCOM- 20020430 LR - 20191105 IS - 0887-9303 (Print) IS - 0887-9303 (Linking) VI - 22 IP - 4 DP - 2000 Feb TI - New antithrombotics for the intensive care unit setting: GP IIb/IIIa inhibitors, low-molecular-weight heparins, and direct thrombin inhibitors. PG - 61-74 AB - Thromboembolic disease (TED) is a frequent problem encountered by clinicians in the intensive care unit (ICU). Traditionally, unfractionated heparin (UFH) has been used in the treatment and prophylaxis of TED. However, newer antithrombotic agents have evolved as effective alternatives to UFH. Low-molecular-weight heparins are effective for both the treatment and prophylaxis of TED. Lepirudin is useful for patients with TED and a history of heparin-induced thrombocytopenia. The platelet glycoprotein IIb/IIIa inhibitors are synergistic with UFH for the treatment of acute coronary syndromes and percutaneous coronary interventions (PCI). Several drugs are now available to clinicians for the treatment and prophylaxis of TED. FAU - DiDomenico, R J AU - DiDomenico RJ AD - Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 60612, USA. rdidom1@uic.edu LA - eng PT - Journal Article PT - Review PL - United States TA - Crit Care Nurs Q JT - Critical care nursing quarterly JID - 8704517 RN - 0 (Fibrinolytic Agents) RN - 0 (Heparin, Low-Molecular-Weight) RN - 0 (Platelet Glycoprotein GPIIb-IIIa Complex) RN - EC 3.4.21.5 (Thrombin) MH - Blood Coagulation/drug effects/physiology MH - *Fibrinolytic Agents/economics/pharmacology/therapeutic use MH - *Heparin, Low-Molecular-Weight/economics/pharmacology/therapeutic use MH - Humans MH - Intensive Care Units MH - Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors MH - Thrombin/*antagonists & inhibitors RF - 72 EDAT- 2002/02/21 10:00 MHDA- 2002/05/01 10:01 CRDT- 2002/02/21 10:00 PHST- 2002/02/21 10:00 [pubmed] PHST- 2002/05/01 10:01 [medline] PHST- 2002/02/21 10:00 [entrez] AID - 10.1097/00002727-200002000-00007 [doi] PST - ppublish SO - Crit Care Nurs Q. 2000 Feb;22(4):61-74. doi: 10.1097/00002727-200002000-00007.